Pittsburgh-based Logical Therapeutics, a developer of drugs for inflammation and metabolic disease, raised $30 million in a second funding round and announced it is moving its headquarters to a location “near Boston.” (What are the odds that the new location …
Roxro Pharmaceuticals, a Menlo Park, Calif., specialty pharmaceutical company focused on pain drugs, raised $42.7 million in a second funding round. The company’s release is here (PDF).
Founded in 1999, Roxro acquires discarded or failed drugs from other companies and …
Aegerion Pharmaceuticals, a Bridgewater, N.J., specialty pharmaceuticals company focused on cardiovascular and metabolic diseases, said it hopes to raise up to $80.5 million in an initial offering, down slightly from its earlier plan to raise as much as $86.5 million. …
Ann Arbor, Mich., specialty pharmaceutical company QuatRx Pharmaceuticals raised $44 million in a fifth funding round following the withdrawal of its initial offering last July. Like the much better-known Jazz Pharmaceuticals, QuatRx acquires drugs from other companies in order to …
Jazz Pharmaceuticals, a Palo Alto, Calif., outfit that licenses and acquires drugs from other companies, said it hopes to raise up to $179.4 million in a 6.9 million share offering — all based on a stable of unexciting drug retreads.…
